Bladder Cancer (MSK/TCGA, 2020)

Summary

Bladder Cancer (MSK/TCGA, 2020) is a study catalogued by cBioPortal DataHub under the cancer-type code blca. EvidenceHelix groups it with kidney and bladder studies and lists it in the TCGA (other releases) collection.

Study description

Whole-exome or targeted sequencing of 476 muscle-invasive bladder tumor/normal pairs via TCGA or MSK-IMPACT sequencing.

Text as published in the source's study metadata.

Citation & PubMed

Pietzak et al. Eur Urol 2019

Linked PubMed records: PMID 30290956

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

blca_msk_tcga_2020

Short name

BLCA (MSK_TCGA 2020)

Source cancer-type code

blca

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data. TCGA data are available under the Broad Institute GDAC TCGA Analysis Pipeline License; TCGA-derived records are preliminary or legacy releases.

Citations

Pietzak et al. Eur Urol 2019

• PubMed record 30290956 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Bladder Cancer (TCGA, Cell 2017)

  Whole-exome sequencing of 412 muscle-invasive bladder tumors and matched normal samples.

  Kidney and bladderTCGA (other releases)Source code blcaPubMed 1

• Bladder Urothelial Carcinoma (TCGA, Nature 2014)

  Whole-exome sequencing of 131 high-grade muscle-invasive urothelial bladder carcinomas

  Kidney and bladderTCGA (other releases)Source code blcaPubMed 1

• Bladder Cancer (MSK, Eur Urol 2014)

  Genomic Predictors of Survival in Patients with High-grade Urothelial Carcinoma of the Bladder. Targeted sequencing of 109 tumor samples (MSKCC, European Urology 2014).

  Kidney and bladderMSK studiesSource code blcaPubMed 1

• Bladder Cancer (MSK, J Clin Onco 2013)

  Comprehensive profiling of 97 high-grade bladder tumors, including targeted sequencing of 15 cancer genes

  Kidney and bladderMSK studiesSource code blcaPubMed 1

• Bladder Cancer (MSK, Nat Genet 2016)

  Whole exome and targeted sequencing of 34 plasmacytoid-variant (signet ring cell) tumors of the bladder

  Kidney and bladderMSK studiesSource code blcaPubMed 1

• Bladder Urothelial Carcinoma (BGI, Nat Genet 2013)

  Whole-exome and whole-genome sequencing of 99 bladder cancer tumor/normal pairs. Generated by BGI.

  Kidney and bladderOther published and consortium studiesSource code blcaPubMed 1

• Bladder Urothelial Carcinoma (DFCI/MSK, Cancer Discov 2014)

  Whole exome sequencing of tumor/normal samples from 50 patients treated with cisplatin-based chemotherapy for muscle invasive urothelial carcinoma.

  Kidney and bladderMSK studiesSource code blcaPubMed 1

• Bladder Urothelial Carcinoma (TCGA, Firehose Legacy)

  TCGA Bladder Urothelial Carcinoma. Source data from GDAC Firehose (http://gdac.broadinstitute.org/runs/stddata__2016_01_28/data/BLCA/20160128/). Previously known as TCGA Provisional.

  Kidney and bladderTCGA Firehose LegacySource code blca

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.